353 / 1631
Developing a balanced approach to risk in
personalising care in early HL ?
•
What is the risk of delivering RT ?
• late toxicity, age of patient, site of disease)
•
What is the risk of
not
delivering RT ?
• reduced disease control, further treatment for
relapse, patient choice)